We are live on
!
Find out more
Brinker Capital Portfolio holdings
AUM
$3.13B
Turnover
16.67%
1-Year Est. Return
9.04%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+9.04%
3 Year Est. Return
+36.1%
5 Year Est. Return
+56.66%
10 Year Est. Return
–
AUM
$2.92B
AUM Growth
+$176M
(+6.4%)
Cap. Flow
+$160M
Cap. Flow
% of AUM
5.47%
Top 10 Holdings %
Top 10 Hldgs %
23.84%
Holding
1,004
New
72
Increased
624
Reduced
235
Closed
71
Avg Time Held
1.9
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$10.9M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$10M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$8.78M |
| 4 |
Conagra Brands
CAG
|
+$6.49M |
| 5 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$5.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quest Diagnostics
DGX
|
+$6.91M |
| 2 |
Walt Disney
DIS
|
+$5.76M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$4.36M |
| 4 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$4M |
| 5 |
Ecolab
ECL
|
+$3.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 35.09% |
| 2 | Technology | 11.57% |
| 3 | Healthcare | 10.23% |
| 4 | Financials | 9.85% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
DELISTED
BioTelemetry, Inc.
BEAT
| $702K | 0.02% |
17,233
+60
| +0.3% | +$2.59K |
2019 Q1
2 quarters
|
|
602
Ametek
AME
$57B
| $701K | 0.02% |
7,636
-121
| -2% | -$10.7K |
2017 Q3
8 quarters
|
|
603
CGI
GIB
$15.5B
| $699K | 0.02% |
8,827
+73
| +0.8% | +$5.69K |
2017 Q1
10 quarters
|
|
604
Toll Brothers
TOL
$12.3B
| $699K | 0.02% |
17,028
-548
| -3% | -$20.2K |
2016 Q4
11 quarters
|
|
|
IMMU
605
DELISTED
Immunomedics Inc
IMMU
| $697K | 0.02% |
52,548
+7,677
| +17% | +$113K |
2019 Q1
2 quarters
|
|
606
HSBC
HSBC
$323B
| $696K | 0.02% |
18,174
+165
| +0.9% | +$6.39K |
2017 Q2
9 quarters
|
|
607
BioMarin Pharmaceuticals
BMRN
$10.8B
| $688K | 0.02% |
+10,201
| New | +$786K |
2019 Q3
0 quarters
|
|
608
Mettler-Toledo International
MTD
$32.8B
| $686K | 0.02% |
974
-243
| -20% | -$178K |
2017 Q3
8 quarters
|
|
609
DELISTED
Meridian Bioscience Inc
VIVO
| $682K | 0.02% |
71,902
+9,653
| +16% | +$102K |
2017 Q4
7 quarters
|
|
|
INXN
610
DELISTED
Interxion Holding N.V.
INXN
| $682K | 0.02% |
8,377
-2,108
| -20% | -$164K |
2017 Q4
7 quarters
|
|
611
Atlanta Braves Holdings Series B
BATRK
$3.17B
| $680K | 0.02% |
24,510
+6,435
| +36% | +$182K |
2018 Q4
3 quarters
|
|
612
Idexx Laboratories
IDXX
$43.1B
| $680K | 0.02% |
2,502
-41
| -2% | -$11.4K |
2017 Q3
8 quarters
|
|
613
Steven Madden
SHOO
$3.38B
| $679K | 0.02% |
18,969
+826
| +5% | +$27.3K |
2017 Q4
7 quarters
|
|
614
Lumentum
LITE
$78.8B
| $678K | 0.02% |
12,656
-4,277
| -25% | -$241K |
2019 Q1
2 quarters
|
|
615
Southwest Gas
SWX
$6.24B
| $678K | 0.02% |
7,447
+635
| +9% | +$57.1K |
2019 Q1
2 quarters
|
|
616
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.74B
| $676K | 0.02% |
25,319
+10,414
| +70% | +$279K |
2018 Q4
3 quarters
|
|
617
BlackLine
BL
$1.77B
| $675K | 0.02% |
14,125
+3,718
| +36% | +$185K |
2019 Q2
1 quarter
|
|
618
TransUnion
TRU
$14.2B
| $671K | 0.02% |
8,267
-128
| -2% | -$10.3K |
2017 Q3
8 quarters
|
|
619
DELISTED
Trinseo
TSE
| $669K | 0.02% |
15,576
+3,236
| +26% | +$121K |
2017 Q1
10 quarters
|
|
|
STL
620
DELISTED
Sterling Bancorp
STL
| $668K | 0.02% |
33,306
+1,386
| +4% | +$28.1K |
2017 Q1
10 quarters
|
|
621
Prudential Financial
PRU
$40.1B
| $665K | 0.02% |
7,398
+832
| +13% | +$75.4K |
2017 Q3
8 quarters
|
|
622
Humana
HUM
$51.9B
| $662K | 0.02% |
2,586
-163
| -6% | -$45.7K |
2017 Q3
8 quarters
|
|
623
iShares Core US REIT ETF
USRT
$4.22B
| $661K | 0.02% |
11,899
-50,133
| -81% | -$2.7M |
2018 Q1
6 quarters
|
|
624
Kyntra Bio
KYNB
$21.7M
| $660K | 0.02% |
714
+81
| +13% | +$89K |
2019 Q1
2 quarters
|
|
625
O'Reilly Automotive
ORLY
$71.6B
| $657K | 0.02% |
24,735
+15
| +0.1% | +$387 |
2017 Q3
8 quarters
|
|
Similar funds
FIM
GFPC
IC
I
MC
FTI
AWM
Brinker Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Brinker Capital held 1,004 positions worth $2.92B, up 6.4% from $2.74B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Brinker Capital deployed $160M of net new capital in Q3 2019, opening 72 new positions and adding to 624 existing holdings. Its largest new stake was Conagra Brands: 225,324 shares worth $6.91M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Quest Diagnostics, an estimated $6.91M trimmed.
- Brinker Capital's largest Q3 2019 buy was Conagra Brands: 225,324 shares worth $6.91M.
- Brinker Capital added most to iShares Core S&P 500 ETF in Q3 2019, an estimated $10.9M increase.
- Brinker Capital's biggest Q3 2019 reduction was Quest Diagnostics, cutting an estimated $6.91M.
- Brinker Capital fully exited Total System Services, Inc. in Q3 2019, selling an estimated $4.36M.
- Brinker Capital's ten largest holdings make up 24% of its $2.92B portfolio in Q3 2019.
- Brinker Capital opened 72 new positions and closed 71 in Q3 2019.
- Brinker Capital's portfolio value rose 6.4% quarter-over-quarter to $2.92B.
Based on Brinker Capital's 13F filing for Q3 2019, filed 21 Oct 2019.